Modern Diagnostic & Research Centre IPO Details

Bookbuilding IPO | ₹37 Cr | Listed at BSE SME | Wed, Dec 31, 2025 - Fri, Jan 2, 2026

Modern Diagnostic IPO Logo

Modern Diagnostic IPO is a book build issue of ₹36.89 crores. The issue is entirely a fresh issue of 0.41 crore shares of ₹36.89 crore.

Modern Diagnostic IPO bidding started from Dec 31, 2025 and ended on Jan 2, 2026. The allotment for Modern Diagnostic IPO was finalized on Jan 5, 2026. Modern Diagnostic IPO will list on BSE SME with a tentative listing date fixed as Jan 7, 2026.

Modern Diagnostic IPO price band is set at ₹90 per share. The lot size for an application is 1,600. The minimum amount of investment required by an individual investor (retail) is ₹2,88,000 (3,200 shares) (based on upper price). The minimum lot size for investment in HNI is 3 lots (4,800 shares), amounting to ₹4,32,000.

Beeline Capital Advisors Pvt.Ltd. is the book running lead manager and MUFG Intime India Pvt.Ltd. is the registrar of the issue. The Market Maker of the company is Spread X Securities Pvt.Ltd..

Refer to Modern Diagnostic IPO RHP for detailed Information.

IPO Open

Wed, Dec 31, 2025

IPO Close

Fri, Jan 2, 2026

Issue Price

₹90 per share

Market Cap (Pre-IPO)

₹135.89 Cr

IPO Details

IPO Date31 Dec, 2025 to 2 Jan, 2026
Listed onWed, Jan 7, 2026
Face Value10 per share
Price Band₹85 to ₹90
Issue Price₹90 per share
Lot Size1,600 Shares
Sale TypeFresh capital only
Issue TypeBookbuilding IPO
Listing AtBSE SME

Total Issue Size40,99,200 shares
(agg. up to ₹37 Cr)
Reserved for Market Maker
2,06,400 shares
(agg. up to ₹2 Cr)
Spread X Securities Pvt.Ltd.
Fresh Issue
(Ex Market Maker)
38,92,800 shares
(agg. up to ₹35 Cr)
Net Offered to Public38,92,800 shares
(agg. up to ₹35 Cr)
Share Holding Pre Issue1,10,00,000 shares
Share Holding Post Issue1,50,99,200 shares
BSE Script Code 544673
ISININE1HK501016

IPO Timetable

Issue Reservation

Modern Diagnostic IPO comprises a total issue size of 40,99,200 shares. The net offer to the public is 38,92,800 shares, after excluding 2,06,400 shares allotted on a firm basis. Of the Net offer 19,44,000 (49.94%) are allocated to QIB, 5,85,600 (15.04%) allocated to NII 13,63,200 (35.02%) allocated to RII.

Investor Category Shares Offered % of Net Issue% of Total Issue
QIB Shares Offered 19,44,00049.94%47.42%
  − Anchor Investor Shares Offered 11,61,60028.34%
  − QIB (Ex. Anchor) Shares Offered 7,82,40019.09%
NII (HNI) Shares Offered 5,85,60015.04%14.29%
  − bNII > ₹10L 3,93,6009.60%
  − sNII < ₹10L 1,92,0004.68%
Retail Shares Offered 13,63,20035.02%33.26%
Firm Reservations
Market Maker Shares Offered 2,06,4005.04%
Total Shares Offered 40,99,200100.00%100.00%

IPO Lot Size

Investors can bid for a minimum of 3,200 shares and in multiples of 1,600 shares thereof. 

Application Lots Shares Amount
Individual investors (Retail) (Min) 2 3,200 ₹2,88,000
Individual investors (Retail) (Max) 2 3,200 ₹2,88,000
S-HNI (Min) 3 4,800 ₹4,32,000
S-HNI (Max) 6 9,600 ₹8,64,000
B-HNI (Min) 7 11,200 ₹10,08,000
IPO Subscription Details

IPO Anchor Investors

Modern Diagnostic IPO raises ₹10.45 crore from anchor investors. Modern Diagnostic IPO Anchor bid date is December 30, 2025.
📝 Anchor Investors Letter (PDF)

Bid DateTue, Dec 30, 2025
Shares Offered11,61,600
Anchor Portion (₹ Cr.)10.45
Anchor lock-in period end date for 50% shares (30 Days)Tue, Feb 3, 2026
Anchor lock-in period end date for remaining shares (90 Days)Sat, Apr 4, 2026

About Modern Diagnostic & Research Centre Ltd.

Incorporated in 1985, Modern Diagnostic & Research Centre Limited (MDRC) is a diagnostic chain in India, offering a comprehensive range of pathology and radiology services.

The company provides reliable diagnostic tests, home specimen collection, online reports, and customized test packages for institutional customers and patients based on their specific needs.

The company operates 21 centers (18 labs, 3 diagnostic centers) across 8 states, offering diagnostic services like ultrasound, CT, MRI, X-ray, ECG, PFT, and specialized labs for heart and neuro care.

Services:

  • Pathology:MDRC provides a wide array of tests, including high-end molecular diagnostics, cytogenetics, and specialized panels for genetic disorders and cancer.
  • Radiology:The centre offers advanced imaging services such as MRI, CT scans, ultrasound, and digital X-rays, utilizing state-of-the-art equipment like a 3-Tesla MRI machine and a 128-slice CT scanner.
  • Home Sample Collection:MDRC offers home blood sample collection services in several cities, providing convenience for patients unable to visit the centre.

Competitive Strengths:

  • Experienced Promoter and Management Team
  • Comprehensive diagnostics provider delivering all-in-one solution at cost-effective prices
  • Focus on quality and customer service
  • Centralized information technology platform

Company Financials (Restated)

Modern Diagnostic & Research Centre Ltd.'s revenue increased by 15% and profit after tax (PAT) rose by 55% between the financial year ending with March 31, 2025 and March 31, 2024.

Period Ended30 Jun 202531 Mar 202531 Mar 202431 Mar 2023
Assets77.8664.5749.4936.54
Total Income22.6778.8068.6756.61
Profit After Tax3.008.975.79-5.73
EBITDA5.8617.9611.05-0.99
NET Worth23.7220.7311.765.96
Reserves and Surplus12.729.7310.764.96
Total Borrowing30.3822.0920.4615.31
Amount in ₹ Crore

IPO Objects of the Issue

The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:

# Issue Objects Est Amt (₹ Cr.)
1 Funding capital expenditure for purchase of medical Equipments for diagnostic centre and laboratories 20.69
2 Funding Working Capital Requirement 8.00
3 Repayment of certain outstanding borrowings availed by the Company 1.00
4 General Corporate Expenses 3.33

Key Performance Indicator (KPI)

Pre IPOPost IPO
EPS (₹)8.157.94
P/E (x)11.0411.33
Promoter Holding99.99%72.85%
Market Cap135.89 Cr.
Mr. Devendra Singh Yadav, Mrs. Deepali Yadav, Mrs. Asha Yadav, and Mr. Jitendra Singh are the promoters of the company.
  • The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue
  • The Pre IPO EPS is calculated based on Pre issue shareholding as on date of RHP and the latest FY earnings as of March 31, 2025 available in RHP.
  • The Post Issue EPS is calculated based on the Post issue shareholding and annualized FY earnings of June 30, 2025 available in RHP.

IPO Review

[Dilip Davda]
MDRCL is a pathology and radiology tests provider with all related services under one roof. The company has its operations in 8 states with 21 centres and is also on expansion spree. With hub and spoke method, it operates asset light operations resulting in higher margins. Despite rising competition and fragmented segment, it hopes to maintain the trends. Based on its recent financial data, the issue appears reasonably priced. Investors can park funds for medium to long term.
Read detail review...

Modern Diagnostic IPO Recommendations

Review BySubscribeMay ApplyNeutralAvoid
Brokers0000
Members0000

IPO Subscription Status

The Modern Diagnostic IPO is subscribed 376.90 times on January 2, 2026 6:19:32 PM (Day 3). The public issue subscribed 342.46 times in the individual investors category, 193.51 times in the QIB category, and 702.08 times in the NII category. Check Day by Day Subscription Details (Live Status)

Category Subscription (x) Shares Offered Shares bid for Total Application
QIB (Ex Anchor)193.517,82,40015,14,00,0000
NII* 702.085,85,60041,11,39,2000
    bNII (bids above ₹10L)855.833,93,60033,68,52,800
    sNII (bids below ₹10L)386.911,92,0007,42,86,400
Individual Investor342.4613,63,20046,68,44,8000
Total376.9027,31,2001,02,93,84,0001,90,121

Total Application : 1,90,121

*Market Maker portion is not included to NII/HNI.

IPO Expenses

# Issue Expenses Est Amt (₹ Cr.)
1 Fees and commissions payable to the BRLM (including any underwriting commission, brokerage and selling commission) 3.05
2 Fees Payable to Registrar to the Issue 0.02
3 Fees payable to Legal Advisor 0.02
4 Fees Payable Advertising, Marketing Expenses and Printing Expenses 0.25
5 Fees Payable to Regulators including Stock Exchanges and other Intermediaries 0.10
6 Fees payable for Financial Due Diligence 0.01
7 Fees payable to Secretarial work 0.04
8 Fees payable to Peer Review Auditor 0.04
9 Fees Payable to Market Maker (for Three Years) 0.09
10 Escrow Bank Fees 0.01
11 Others (Fees payable for marketing & distributing expenses, selling commission, brokerage, processing fees and miscellaneous expenses) 0.25

Listing Day Trading Information

Price DetailsBSE SME
Final Issue Price90.00
Open99.50
Low94.53
High100.00
Last Trade94.99

Check IPO Performance…

IPO Registrar

MUFG Intime India Pvt.Ltd.

  • +91-22-4918 6270
  • moderndiagnostic.smeipo@in.mpms.mufg.com
  • Visit Website

Contact Details

Modern Diagnostic & Research Centre Ltd. Address
Plot No H-64,1st Floor BLK-H,
Bali Nagar City landmark near Khetar Pal Hospital,
Ramesh Nagar, West Delhi
West Delhi, New Delhi, 110015
Open an Instant Account with Zerodha

IPO FAQs

Modern Diagnostic IPO is a SME IPO of 40,99,200 equity shares of the face value of ₹10 aggregating up to ₹37 Crores. The issue is priced at ₹90 per share. The minimum order quantity is 1600.

The IPO opens on Wed, Dec 31, 2025, and closes on Fri, Jan 2, 2026.

MUFG Intime India Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE SME.

Zerodha customers can apply online in Modern Diagnostic IPO using UPI as a payment gateway. Zerodha customers can apply in Modern Diagnostic IPO by login into Zerodha Console (back office) and submitting an IPO application form.

Steps to apply in Modern Diagnostic IPO through Zerodha

  1. Visit the Zerodha website and login to Console.
  2. Go to Portfolio and click the IPOs link.
  3. Go to the 'Modern Diagnostic IPO' row and click the 'Bid' button.
  4. Enter your UPI ID, Quantity, and Price.
  5. Submit IPO application form.
  6. Visit the UPI App (net banking or BHIM) to approve the mandate.

Visit Zerodha IPO Application Process Review for more detail.

The Modern Diagnostic IPO opens on Wed, Dec 31, 2025 and closes on Fri, Jan 2, 2026.

Modern Diagnostic IPO lot size is 1600, and the minimum amount required for application is ₹2,88,000, with 2 lots being the minimum application size.

You can apply in Modern Diagnostic IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.

The finalization of Basis of Allotment for Modern Diagnostic IPO will be done on Monday, January 5, 2026, and the allotted shares will be credited to your demat account by Tue, Jan 6, 2026. Check the Modern Diagnostic IPO allotment status.

The Modern Diagnostic IPO listing date is on Wed, Jan 7, 2026.

Compare: